Phosphatidylinositol 4-Kinase III Alpha Governs Cytoskeletal Organization for Invasiveness of Liver Cancer CellsGASTROENTEROLOGYIF25.12024-08-010OA
Distinct roles of vaccine-induced SARS-CoV-2-specific neutralizing antibodies and T cells in protection and diseaseMOLECULAR THERAPYIF122024-02-010OAAI
A universal SARS-CoV DNA vaccine inducing highly cross-reactive neutralizing antibodies and T cellsEMBO MOLECULAR MEDICINEIF8.32022-09-0213OAAI
Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 PatientsJOURNAL OF IMMUNOLOGYIF3.42020-11-0159OAAI
Blocking Entry of Hepatitis B and D Viruses to Hepatocytes as a Novel Immunotherapy for Treating Chronic InfectionsJOURNAL OF INFECTIOUS DISEASESIF4.52020-01-2914OAAI
Designing a therapeutic hepatitis B vaccine to circumvent immune toleranceHUMAN VACCINES & IMMUNOTHERAPEUTICSIF3.52019-12-0617OAAI
Hepatitis C Virus-Specific T Cell Receptor mRNA-Engineered Human T Cells: Impact of Antigen Specificity on Functional PropertiesJOURNAL OF VIROLOGYIF3.82017-05-0114OAAI
Functional differences in hepatitis C virus nonstructural (NS) 3/4A-and 5A-specific T cell responsesSCIENTIFIC REPORTSIF3.92016-05-040OAAI
Prospects and progress of DNA vaccines for treating hepatitis BEXPERT REVIEW OF VACCINESIF4.82016-01-286PRE
Functional Aspects of Intrahepatic Hepatitis B Virus-specific T Cells Induced by Therapeutic DNA VaccinationMOLECULAR THERAPYIF122015-03-0115OAAI
Electroporation for therapeutic DNA vaccination in patientsMEDICAL MICROBIOLOGY AND IMMUNOLOGYIF32014-12-2325PREAI
A THERAPEUTIC VACCINE BASED ON THE HEPATITIS B CORE ANTIGEN IN COMBINATION WITH INTERLEUKIN-12 EFFECTIVELY INDUCES IMMUNE RESPONSES IN HBV-TRANSGENIC MICEJOURNAL OF HEPATOLOGYIF332014-04-010PREAI
EVALUATION OF A HEPATITIS C VIRUS THERAPEUTIC VACCINE CANDIDATE IN WILDTYPE- AND HCV-TRANSGENIC MICEJOURNAL OF HEPATOLOGYIF332014-04-010PREAI
HEPATITIS C NONSTRUCTURAL PROTEIN 3/4A DAMPENS INFLAMMATION AND CONTRIBUTES TO SLOW FIBROSIS PROGRESSION DURING CHRONIC LIVER INJURY IN MICEJOURNAL OF HEPATOLOGYIF332014-04-010OAAI
Therapeutic DNA Vaccination Using In Vivo Electroporation Followed by Standard of Care Therapy in Patients With Genotype 1 Chronic Hepatitis CMOLECULAR THERAPYIF122013-09-0159OAAI
Containing The Great Houdini of viruses: Combining direct acting antivirals with the host immune response for the treatment of chronic hepatitis CDRUG RESISTANCE UPDATESIF21.72013-07-0114OAAI
A Heterologous Prime/Boost Vaccination Strategy Enhances the Immunogenicity of Therapeutic Vaccines for Hepatitis C VirusJOURNAL OF INFECTIOUS DISEASESIF4.52013-06-1754OAAI
HEPATITIS C VIRUS NON-STRUCTURAL 3/4A PROTEIN EXPRESSION PROMOTES HEPATIC FIBROGENESIS IN MICE AFTER ADMINISTRATION OF CARBON TETRACHLORIDEJOURNAL OF HEPATOLOGYIF332013-04-010OAAI
A Synthetic Codon-Optimized Hepatitis C Virus Nonstructural 5A DNA Vaccine Primes Polyfunctional CD8+ T Cell Responses in Wild-Type and NS5A-Transgenic MiceJOURNAL OF IMMUNOLOGYIF3.42013-02-0113OA
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向